Rektorová Irena, Pupíková Monika, Fleury Lisa, Brabenec Luboš, Hummel Friedhelm C
Applied Neuroscience Research Group, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
First Department of Neurology, Faculty of Medicine and St. Anne's University Hospital, Masaryk University, Brno, Czech Republic.
Nat Rev Neurol. 2025 Sep 16. doi: 10.1038/s41582-025-01137-z.
Device-based non-invasive brain stimulation (NIBS) techniques show promise for the treatment of neurological and psychiatric disorders, although inconsistencies in protocol designs and study findings can make the field difficult to navigate. In this Review, we discuss applications of NIBS for enhancing cognitive and motor function in people with various neurological diseases that are characterized by disruption of large-scale brain networks, including neurodegenerative diseases and brain lesion disorders such as stroke and traumatic brain injury. In particular, we focus on repetitive transcranial magnetic stimulation and transcranial electrical stimulation, as these techniques have been widely used in clinical settings and randomized controlled trials. We summarize and synthesize current knowledge, and highlight gaps and shortcomings in the existing research that make it difficult to draw firm conclusions, including small sample sizes, heterogeneous patient populations and variations in stimulation protocols. We believe that a rapid evolution of NIBS techniques from state-dependent, network-informed, multifocal and subcortical paradigms to individualized electric field modelling and accelerated NIBS protocols will improve the management of neurological disorders. However, realizing this potential will require us to address crucial challenges and acquire deeper mechanistic insights, with the aim of developing adaptive, biomarker-driven protocols to optimize target engagement, dosing and timing for each patient.
基于设备的无创脑刺激(NIBS)技术在治疗神经和精神疾病方面显示出前景,尽管方案设计和研究结果存在不一致性,使得该领域难以把握。在本综述中,我们讨论了NIBS在增强各种神经疾病患者认知和运动功能方面的应用,这些疾病的特征是大规模脑网络中断,包括神经退行性疾病以及中风和创伤性脑损伤等脑损伤疾病。特别是,我们重点关注重复经颅磁刺激和经颅电刺激,因为这些技术已在临床环境和随机对照试验中广泛应用。我们总结并综合了当前的知识,并强调了现有研究中的差距和不足,这些使得难以得出确凿的结论,包括样本量小、患者群体异质性以及刺激方案的差异。我们相信,NIBS技术从依赖状态、基于网络、多焦点和皮层下范式快速发展到个性化电场建模和加速NIBS方案,将改善神经疾病的管理。然而,要实现这一潜力,我们需要应对关键挑战并获得更深入的机制见解,目的是开发适应性的、由生物标志物驱动的方案,以优化每个患者的靶点参与、剂量和时机。